Cerebrolysin combined with rehabilitation promotes motor recovery in patients with severe motor impairment after stroke

BMC Neurology

Volumn 16, Issue 1, 2016, Pages

  Chang, Won Hyuk ^a   Park, Chang hyun ^a   Kim, Deog Young ^b   Shin, Yong Il ^c   Ko, Myoung Hwan ^d   Lee, Ahee ^e   Jang, Shin Yi ^f   Kim, Yun Hee ^a,e  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Pusan National University Yangsan Hospital   (South Korea)

^d Chonbuk National University Medical School   (South Korea)

^e Sungkyunkwan University   (South Korea)

^f Samsung Medical Center   (South Korea)

Author keywords

Cerebrolysin; Imaging; Motor recovery; Rehabilitation; Stroke; Subacute therapy

Indexed keywords

CEREBROLYSIN; PLACEBO; AMINO ACID;

ADULT; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; CONVALESCENCE; DIFFUSION TENSOR IMAGING; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; MALE; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; MOTOR SYSTEM; NERVE CELL PLASTICITY; PARALLEL DESIGN; PHASE 4 CLINICAL TRIAL; PROSPECTIVE STUDY; PYRAMIDAL TRACT; RANDOMIZED CONTROLLED TRIAL; REHABILITATION CARE; SENSORIMOTOR FUNCTION; STROKE PATIENT; TREATMENT DURATION; AGED; CLINICAL TRIAL; MIDDLE AGED; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PROCEDURES; STROKE; STROKE REHABILITATION; TREATMENT OUTCOME;

AGED; AMINO ACIDS; COMBINED MODALITY THERAPY; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; STROKE; STROKE REHABILITATION; TREATMENT OUTCOME;

EID: 84959285210     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/s12883-016-0553-z     Document Type: Article

References (42)

1. Stinear C. Prediction of recovery of motor function after stroke. Lancet Neurol. 2010;9:1228-32.
2. Langhorne P, Bernhardt J, Kwakkel G. Stroke rehabilitation. Lancet. 2011;377:1693-702.
3. Tallabs FA, Hammond-Tooke GD. Theta Priming of 1-Hz rTMS in Healthy Volunteers: Effects on Motor Inhibition. J Clin Neurophysiol. 2013;30:79-85.
4. Counsell C, Dennis M, McDowall M, Warlow C. Predicting outcome after acute and subacute stroke: development and validation of new prognostic models. Stroke. 2002;33:1041-7.
5. Cramer SC. Repairing the human brain after stroke. II. Restorative therapies. Ann Neurol. 2008;63:549-60.
6. Cramer SC. Repairing the human brain after stroke: I. Mechanisms of spontaneous recovery. Ann Neurol. 2008;63:272-87.
7. Darsalia V, Heldmann U, Lindvall O, Kokaia Z. Stroke-induced neurogenesis in aged brain. Stroke. 2005;36:1790-5.
8. Heiss WD, Brainin M, Bornstein NM, Tuomilehto J, Hong Z. Cerebrolysin Acute Stroke Treatment in Asia I. Cerebrolysin in patients with acute ischemic stroke in Asia: results of a double-blind, placebo-controlled randomized trial. Stroke. 2012;43:630-6.
9. Amiri-Nikpour MR, Nazarbaghi S, Ahmadi-Salmasi B, Mokari T, Tahamtan U, Rezaei Y. Cerebrolysin effects on neurological outcomes and cerebral blood flow in acute ischemic stroke. Neuropsychiatr Dis Treat. 2014;10:2299-306.
10. Tatebayashi Y. The dentate gyrus neurogenesis: a common therapeutic target for Alzheimer disease and senile depression? Seishin Shinkeigaku Zasshi. 2003;105:398-404.
11. Akai F, Hiruma S, Sato T, Iwamoto N, Fujimoto M, Ioku M, et al. Neurotrophic factor-like effect of FPF1070 on septal cholinergic neurons after transections of fimbria-fornix in the rat brain. Histol Histopathol. 1992;7:213-21.
12. Fugl-Meyer AR, Jaasko L, Leyman I, Olsson S, Steglind S. The post-stroke hemiplegic patient. 1. a method for evaluation of physical performance. Scand J Rehabil Med. 1975;7:13-31.
13. Oh MS, Yu KH, Lee JH, Jung S, Ko IS, Shin JH, et al. Validity and Reliability of a Korean Version of the National Institutes of Health Stroke Scale. J Clin Neurol. 2012;8:177-83.
14. Sullivan KJ, Tilson JK, Cen SY, Rose DK, Hershberg J, Correa A, et al. Fugl-Meyer assessment of sensorimotor function after stroke: standardized training procedure for clinical practice and clinical trials. Stroke. 2011;42:427-32.
15. Behrens TE, Woolrich MW, Jenkinson M, Johansen-Berg H, Nunes RG, Clare S, et al. Characterization and propagation of uncertainty in diffusion-weighted MR imaging. Magn Reson Med. 2003;50:1077-88.
16. Basser PJ, Pierpaoli C. Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. 1996. J Magn Reson. 2011;213:560-70.
17. Park C-h, Kou N, Boudrias M-H, Playford ED, Ward NS. Assessing a standardised approach to measuring corticospinal integrity after stroke with DTI. Neuroimage Clin. 2013;2:521-33.
18. Chang WH, Kim YH, Yoo WK, Goo KH, Park CH, Kim ST, et al. rTMS with motor training modulates cortico-basal ganglia-thalamocortical circuits in stroke patients. Restor Neurol Neurosci. 2012;30:179-89.
19. Lehr R. Sixteen S-squared over D-squared: a relation for crude sample size estimates. Stat Med. 1992;11:1099-102.
20. Fugl-Meyer AR. Post-stroke hemiplegia assessment of physical properties. Scand J Rehabil Med Suppl. 1980;7:85-93.
21. Murphy TH, Corbett D. Plasticity during stroke recovery: from synapse to behaviour. Nat Rev Neurosci. 2009;10:861-72.
22. Adams Jr HP, Nudo RJ. Management of patients with stroke: is it time to expand treatment options? Ann Neurol. 2013;74:4-10.
23. Satou T, Itoh T, Tamai Y, Ohde H, Anderson AJ, Hashimoto S. Neurotrophic effects of FPF-1070 (Cerebrolysin) on cultured neurons from chicken embryo dorsal root ganglia, ciliary ganglia, and sympathetic trunks. J Neural Transm. 2000;107:1253-62.
24. Reinprecht I, Gschanes A, Windisch M, Fachbach G. Two peptidergic drugs increase the synaptophysin immunoreactivity in brains of 24-month-old rats. Histochem J. 1999;31:395-401.
25. Alcantara-Gonzalez F, Mendoza-Perez CR, Zaragoza N, Juarez I, Arroyo-Garcia LE, Gamboa C, et al. Combined administration of cerebrolysin and donepezil induces plastic changes in prefrontal cortex in aged mice. Synapse. 2012;66:938-49.
26. Rockenstein E, Mallory M, Mante M, Alford M, Windisch M, Moessler H, et al. Effects of Cerebrolysin on amyloid-beta deposition in a transgenic model of Alzheimer's disease. J Neural Transm Suppl 2002;62:327-36.
27. Rockenstein E, Adame A, Mante M, Moessler H, Windisch M, Masliah E. The neuroprotective effects of Cerebrolysin in a transgenic model of Alzheimer's disease are associated with improved behavioral performance. J Neural Transm. 2003;110:1313-27.
28. Zhang C, Chopp M, Cui Y, Wang L, Zhang R, Zhang L, et al. Cerebrolysin enhances neurogenesis in the ischemic brain and improves functional outcome after stroke. J Neurosci Res. 2010;88:3275-81.
29. Zhang L, Chopp M, Meier DH, Winter S, Wang L, Szalad A, et al. Sonic hedgehog signaling pathway mediates cerebrolysin-improved neurological function after stroke. Stroke. 2013;44:1965-72.
30. Ren J, Sietsma D, Qiu S, Moessler H, Finklestein SP. Cerebrolysin enhances functional recovery following focal cerebral infarction in rats. Restor Neurol Neurosci. 2007;25:25-31.
31. Gladstone DJ, Danells CJ, Black SE. The fugl-meyer assessment of motor recovery after stroke: a critical review of its measurement properties. Neurorehabil Neural Repair. 2002;16:232-40.
32. Budde MD, Kim JH, Liang HF, Schmidt RE, Russell JH, Cross AH, et al. Toward accurate diagnosis of white matter pathology using diffusion tensor imaging. Magn Reson Med. 2007;57:688-95.
33. Song AW, Harshbarger T, Li T, Kim KH, Ugurbil K, Mori S, et al. Functional activation using apparent diffusion coefficient-dependent contrast allows better spatial localization to the neuronal activity: evidence using diffusion tensor imaging and fiber tracking. Neuroimage. 2003;20:955-61.
34. Lindenberg R, Zhu LL, Ruber T, Schlaug G. Predicting functional motor potential in chronic stroke patients using diffusion tensor imaging. Hum Brain Mapp. 2012;33:1040-51.
35. Park CH, Chang WH, Ohn SH, Kim ST, Bang OY, Pascual-Leone A, et al. Longitudinal changes of resting-state functional connectivity during motor recovery after stroke. Stroke. 2011;42:1357-62.
36. Feigin VL, Barker-Collo S, Parag V, Senior H, Lawes CM, Ratnasabapathy Y, et al. Auckland Stroke Outcomes Study. Part 1: Gender, stroke types, ethnicity, and functional outcomes 5years poststroke. Neurology. 2010;75:1597-607.
37. Bernhardt J, Dewey H, Thrift A, Collier J, Donnan G. A very early rehabilitation trial for stroke (AVERT): phase II safety and feasibility. Stroke. 2008;39:390-6.
38. Slot KB, Berge E, Dorman P, Lewis S, Dennis M, Sandercock P, et al. Impact of functional status at six months on long term survival in patients with ischaemic stroke: prospective cohort studies. BMJ. 2008;336:376-9.
39. Toschke AM, Tilling K, Cox AM, Rudd AG, Heuschmann PU, Wolfe CD. Patient-specific recovery patterns over time measured by dependence in activities of daily living after stroke and post-stroke care: the South London Stroke Register (SLSR). Eur J Neurol. 2010;17:219-25.
40. Ovadia-Caro S, Margulies DS, Villringer A. The value of resting-state functional magnetic resonance imaging in stroke. Stroke. 2014;45:2818-24.
41. Jang SH. A review of diffusion tensor imaging studies on motor recovery mechanisms in stroke patients. NeuroRehabilitation. 2011;28:345-52.
42. Ziganshina LE, Abakumova T. Cerebrolysin for acute ischaemic stroke. Cochrane Database Syst Rev. 2015;6:CD007026.